Gwyn Tudor Forum Manager - MediWales

Slides:



Advertisements
Similar presentations
West Midlands Academic Health Science Network July 24 th 2013.
Advertisements

Invention for Innovation (i4i) Programme Dr Martin Anyim i4i Assistant Director 09/10/2013.
Case study: The National Library for Health (NLH) Specialist Libraries An example of a Community of Practice.
Tony Davis CEO of Medilink WMAHSN Working With Industry and Wealth Creation.
Access to Medicines: what should the industry contribute? Part II: Supply Chain & Delivery Systems - The Last Mile Challenge EFPIA 18 th September 2013.
Driving Innovation Concept to Commercialisation A strategy for business innovation, Zahid Latif Head of Healthcare Mark Glover 12 th January.
Recognising and Supporting Apprenticeships in the Life Sciences Sector The LAC Apprenticeship Working Group.
23 rd November 2011 MCST Conference: Amplifying the Competitiveness of Manufacturing in Malta Industry’s views of Research for Competitiveness Ing. Ray.
Engaging regional health systems in the knowledge economy: lessons learnt so far Professor Jonathan Watson PhD FRSM HCN Executive Director EUREGIO III.
ICT for Health. Kieran Drain CEO, Tyndall National Institute.
AusIndustry Martin Cebis AusIndustry – Entrepreneur Development Facilitator.
Prof. Brian MacCraith, Director, Biomedical Diagnostics Institute, DCU DCU, November 3, 2005 Leadership in a Changing Research Environment.
Introducing The Innovation Pathway AHSN Stakeholder Event Dr Nicola Wesley 2 nd half of presentation 23 rd June 2015.
Creu llwyddiant gyda’n gilydd dros Gymru Creating success together for Wales Wales Innovation Relay Centre Dr Sharon Thomas Healthcare & Life Science Specialist.
Cels – Driving the Business of Life Sciences NEPIC Innovation Day, November 2011 Dr Mike Nicholds.
WEFO’s Horizon 2020 Unit: supporting Welsh organisations Geraint Green Head of Horizon 2020 Unit Welsh European Funding Office.
Access to Clinical Expertise Steve Bain David Powell Jemma Hughes Paula Jeffries.
Criteria for Centres of Expertise for Rare Diseases in the EU following EUCERD Recommendations RARECARENet Project: Consensus meeting on.
Nathan Tinker Executive Director New York Biotechnology Association New York BizBio 2009 Fighting for a Healthy Biotech Industry.
Innovation Pathway AHSN Stakeholder Event Russ Watkins Assistant Director – Business Innovation & Improvement Newcastle Hospitals.
Invention for Innovation (i4i) Bev Luchmun Industry Lead NISCHR
How to determine medicines benefits policy and program needs?
Integrating Innovation
Barriers to innovation – and solutions The Collaboration Conundrum Colette Goldrick, Director ABPI Northern Ireland.
Developing a National Critical Care Clinical Research Network: what’s in it for trainees? Paul Dark Associate Professor, Faculty of Medical and Human Sciences,
1 Positioning Canada as a Global Leader in Healthcare Delivery through ICT Repeatable Public-Private Model May 27, 2013.
NHS England New Structure and Industry Engagement Richard Stubbs Head of Commercial and International Innovation NHS England.
Helping to Deliver Quality Care. Over 35 years experience Supplying NHS Trusts, Private Hospitals and Distributors Established 1977 Acquired by Berendsen.
Audit of Innovation in the BMW Region An Evaluation of a Regional Knowledge Economy Gerry Finn, Director.
Engaging with Clinical Commissioning Groups (CCGs)
Formal agreement between the CCG, City Council, Salford Royal and Greater Manchester West –Pooled health & social care budget and financial risk share.
Policy on the Management of Intellectual Property in Technology Transfer Activities at CERN CERN/FC/5434/RA Technology Transfer Network Meeting – 10 th.
0 International Medical Cluster (IMC), to be established in Moscow, creates a unique framework for developing healthcare business: –IMC activities are.
Roadmap Economic Impact & Funding Opportunities Dr Stephen Hillier
David Taylor The Art of City Making Birmingham 30 October 2004 Developing Medical and Healthcare Potential.
Supplier Showcase Event 22 April Welsh Life Science The Life Science Network For Wales.
European network for Health Technology Assessment | JA | EUnetHTA European network for Health Technology Assessment THL Info.
Manchester 15 th November m-Health Innovation Centre (mHIC) Established 2008 In partnership with GSMA Multidisciplinary informatics capability.
EUROPEAN HUB EU Funds for SMEs and Startups Innovation and Investment.
Welsh Wound Network.
Knowledge for Healthcare: Driver Diagrams October 2016
Insider Connectivity Review & Savings Analysis
Alternative delivery models in public services
What do we do? Through our industry and enterprise programmes we:
NIHR Invention for Innovation (i4i)
Dr Chris Parker CBE Managing Director WMAHSN
Our Vision Our Purpose What we do Our Strategic Aims
Trial Innovation Network Uncovering Grand Opportunities
Executive Structure – 1 September 2012
Dr. Simone Borsci DEC London
The Industrial Strategy Challenge Fund & the Focus on Life Sciences
Knowledge Exchange Networks
Research for all Sharing good practice in research management
Welsh Health Innovation Technology Accelerator
NHS procurement The HealthTech industry view
Engage & Adapt We need each other
Background Resources Sector engagement with Indigenous economic participation CSRM an early and key player – knowledge and solutions Employment Agreements.
Introduction to the Academic Health Science Network (AHSN NENC)
AIDS Resource Center Wisconsin – Prophix story
Working in Collaboration across the Health and Care System
An Introduction to the NIHR programmes
1.05 Effective Healthcare Teams
Kaisa Immonen EPF Director of Policy
Self Care in Glossop.
NICHE offers health informatics R&D expertise in:
OUR HISTORY & MISSION ABOUT US. OUR HISTORY & MISSION ABOUT US.
Head of Corporate Governance/ Board Secretary
Agenda Welcome & Introductions
Connects – 2nd July 2019 Denise Puckett – Head of Health & Care Engagement, Life Science Hub Wales  
A Successful Partnership Unilever & Nottingham
Presentation transcript:

Gwyn Tudor Forum Manager - MediWales Clinical Access Gwyn Tudor Forum Manager - MediWales

MediWales ABC Established 1992 140 members from industry, academic and clinical organisations in Wales Owned by its members with directors drawn from senior members of the sector Networking Representation Communication Academic Clinical Business

Welsh Life Science Companies Manufacturing strengths 322 Companies 15,000 Employees (2008) £1.3Bn Turnover (2008) £19% Growth over 3 years (2009) Including (2009) Medical Technology companies 27 Medical Biotechnology companies Manufacturing strengths Wound care Aids for the disabled and mobility Diagnostics Pharmaceutical supply chain Academia 183 academic (life science) groups each with annual income of over £250k pa

Clinical Access Purpose Initiated as a response to the economic downturn. MediWales asked its members what was the most important factor to their success and survival in difficult economic times. The most common response was the need for cost effective, appropriate and timely access to clinical expertise and facilities during new product development and introduction. This was considered a more difficult issue to address than access to finance and funding.

Clinical Access Findings R&D collaboration with industry can deliver improved patient care, reduced healthcare costs and economic benefits. Appropriate industry engagement can result in commercial, research and technology that benefits healthcare organisations. However there can be a lack of visible, appropriate points of contact for initial engagement with healthcare organisations. There can be confusion derived from terminology and there can be a lack of motivators to deliver on time, on budget or as discussed in project agreements. Four main stages in need of clinical expertise during product development Initial idea screening Evidence gathering and clinical trials Product evaluation Procurement of new technologies and/or solutions

Recommendations Online, interactive, visual Clinical Access Route Map Directory of expertise Glossary of standard terms Publication of standard product testing procedures Network of clinical academic and business organisations Structured dedicated industry liaison roles within the NHS NHS IP commercialisation strategy

Improve patient care Reduce healthcare costs Deliver economic growth Thank you